Mon MM, Srisomsap C, Chokchaichamnankit D, Watcharatanyatip K, Weeraphan C, Svasti J, Maneechai K, Thongsuksai P, Raungrut P*.
Anticancer Res. 2021 Apr;41(4):1871-1882.
To find the 2nd edition, type "2nd edition"
Mon MM, Srisomsap C, Chokchaichamnankit D, Watcharatanyatip K, Weeraphan C, Svasti J, Maneechai K, Thongsuksai P, Raungrut P*.
Anticancer Res. 2021 Apr;41(4):1871-1882.
Ngiwsara L, Vatanavicharn N*, Sawangareetrakul P, Liammongkolkul S, Ratanarak P, Boonyawat B, Srisomsap C, Champattanachai V, Ketudat-Cairns J, Wasant P, Svasti J.
Mol Biol Rep. 2021 Mar;48(3):2063-2070.
Saengow VE, Chiangjong W, Khongkhatithum C, Changtong C, Chokchaichamnankit D, Weeraphan C, Kaewboonruang P, Thampratankul L, Manuyakorn W, Hongeng S, Srisomsap C, Svasti J, Chutipongtanate S, Visudtibhan A.
Brain Dev. 2021 Mar;43(3):431-439.
Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer.
Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*.
Glycoconj J. 2021 Feb;38(1):55-65.
Effect of Expression of Human Glucosylceramidase 2 Isoforms on Lipid Profiles in COS-7 Cells.
Jatooratthawichot P, Talabnin C, Ngiwsara L, Rustam YH, Svasti J, Reid GE, Ketudat Cairns JR.
Metabolites. 2020 Nov 27;10(12):488.